The Company Behind the ‘Steroid Olympics’ Wants To Make Enhanced Pro Athletes Mainstream—and Amateurs, Too
Hello and welcome to another edition of Free Agent! It’s a great week to grate some cheese thanks to the new food pyramid. Today’s edition is a really interesting conversation with Max Martin, CEO of Enhanced. His firm is launching the Enhanced Games in May, which will feature athletes who have been using performance-enhancing substances […]
FDA requests removal of suicide warnings from weight-loss drugs
The request follows a review by the FDA that found no evidence linking GLP-1 receptor agonists to an increased risk of suicidal thoughts or behavior.
Why 2026 is Already a NIGHTMARE for China | China Decode
In the wake of Trump’s invasion of Venezuela, how will China respond to the ongoing protests in Iran? In this episode of China Decode, Alice Han and James Kynge take on the geopolitical firestorm brewing in Beijing, as it finds its energy imports, financial partnerships, and global influence all imperiled. Alice and James are joined […]
New fleet of weight loss drugs are more effective than the current popular obesity medications at trial
One in eight Americans are taking a GLP-1 drug, a recent poll found
Ro Partners With Amgen to Study Barriers to Obesity Care, GLP-1 Access
Jan 13 (Reuters) – U.S. telehealth firm Ro said on Tuesday it has entered a research collaboration with drugmaker Amgen to examine challenges…
Eli Lilly vs Novo Nordisk: Which Company Will Dominate the Weight Loss Drug Market in 2026?
Key Points Eli Lilly and Novo Nordisk make the world’s most popular weight loss drugs. These injectable products have generated double-digit growth, with revenue reaching blockbuster levels. 10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) have seen revenue climb in recent years thanks to their […]
FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications
FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications
FDA asks Lilly, Novo to remove suicide warning related to GLP-1 obesity drugs
Post Content
Aon’s Latest GLP-1 Research Reveals Long-Term Employer Cost Savings and Significant Reductions in Cancer Risk for Women
CHICAGO, Jan. 13, 2026 /PRNewswire/ — Aon plc (NYSE: AON), a leading global professional services firm, today released updated findings from its multi-year study of U.S. commercial health claims data, building on its GLP-1 research first released in April 2025. Drawing on medical and…
Parents weighing GLP-1 drugs for kids | Morning in America
Obesity now affects roughly 20% of U.S. children, according to the CDC, and families are searching for solutions that could include injectable weight loss drugs such as Wegovy. NewsNation’s Elizabeth Prann spoke with nurse practitioner Yarickza Lopez about what parents should consider when it comes to GLP-1 drugs and their kids. Watch more of Prann’s […]